Cypress Capital Group »

Abbvie shares owned by Cypress Capital Group

Quarter-by-quarter ownership of Abbvie (ABBV) shares owned by Cypress Capital Group from 13F filings

Historical chart of Cypress Capital Group investment in Abbvie

Tip: Access up to 7 years of quarterly data

All positions including Abbvie held by Cypress Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abbvie by Cypress Capital Group

Quarter filed Position value Share count Share price at filing
2013-03-31 $7.2M 177k 40.78

More positions owned by Cypress Capital Group

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Visa Com Cl A (V)
Abbvie (ABBV)
Lockheed Martin Corporation (LMT)
Ishares Tr Core S&p Mcp Etf (IJH)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Accenture Plc Ireland Shs Class A (ACN)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
TJX Companies (TJX)

View all positions for Cypress Capital Group

Top funds holding Abbvie

Vanguard Group
Jpmorgan Chase & Co
Charles Schwab Investment Management
Bank of New York Mellon
Norges Bank Investment Management
Bank of America Corporation
Legal & General Group
UBS Group
Goldman Sachs Group
Henderson Group
Wells Fargo & Company
T. Rowe Price Associates
Ubs Global Asset Management Americas
Royal Bank of Canada
Massachusetts Financial Services

View all funds holding Abbvie